Cetraxal Otic Drops, Solution 0.2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Cetraxal: Otic drops, solution (0.2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CIPROFLOXACIN (sip roe FLOX a sin) is used to treat ear infections.

In-Depth Information

Cetraxal 0.2% Otic Solution

NDC: 669920450
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Otitis Externa

Storage Information
Protect from light
Store in original container
Store between 59 to 77 degrees F
Cetraxal 0.2% Otic Solution

Reported Side Effects for Cetraxal 0.2% Otic Solution

Vesicular Rash Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Darkened Skin Patches Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Rash Of Red Skin Bumps Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Redness Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Blistery Rash Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<3.0%*
Severity: MILD
Onset: RAPID
Headache Incidence:
<3.9%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<2.1%*
Severity: MILD
Onset: EARLY
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Skin Rash Incidence:
1.0-1.8%*
Severity: MILD
Onset: EARLY
Superinfection Incidence:
1.8-3.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cetraxal

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5